Please Wait.....
Report
South Korea Nuclear Imaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-08-01 I 70 Pages I Mordor Intelligence
South Korea Nuclear Imaging Market Analysis
The South Korea nuclear medicine market size is valued at USD 195.82 million in 2025 and is projected to reach USD 287.63 million by 2030, advancing at an 8.04% CAGR over the forecast period. Robust demand for precision oncology diagnostics, expanding domestic radioisotope production, and rapid integration of artificial intelligence (AI) into imaging workflows collectively underpin this trajectory. Continued build-out of cyclotron capacity, coupled with favorable reimbursement for neurology PET tracers, is widening clinical adoption beyond the Seoul-Busan corridor. Private-sector hospital investment is shortening equipment refresh cycles, while international medical-tourism inflows stimulate premium diagnostic services. Persistent supply-chain fragility for imported isotopes and workforce shortages in nuclear-medicine technologists remain structural headwinds.
South Korea Nuclear Imaging Market Trends and Insights
Growing Oncology PET/CT Demand Driven by an Aging Population
Korea's population aged 65 plus will reach 20.3% in 2025, placing sustained pressure on oncology imaging capacity. High-sensitivity PET/CT scanners deployed at the National Cancer Center show markedly improved lesion detection in prostate cancer, achieving 86.9% accuracy with 68Ga-NGUL tracers. Hospitals are accelerating procurement schedules, with Yonsei Cancer Center adding a carbon-ion facility that began treating patients in 2023. Parallel clinical-trial data demonstrate 49.5% objective response rates for targeted alpha therapy in neuroendocrine tumors. These factors combine to keep the South Korea nuclear medicine market firmly anchored in oncology leadership.
Government Reimbursement Expansion for Dementia PET Tracers
The Health Insurance Review and Assessment Service widened coverage for amyloid and tau PET imaging in January 2025, cutting patient co-payments by 18%. The policy supports a projected trebling of dementia prevalence by 2050, intensifying demand for early PET-based diagnosis. Seoul-based tertiary centers report 92% diagnostic accuracy when pairing AI analytics with PET for mild cognitive impairment screening. Expanded insurance coverage thereby sustains medium-term volume growth for the South Korea nuclear medicine market.
Radiopharmaceutical Supply-Chain Intermittency
The October 2024 European reactor outage slashed Mo-99 output by 50%, forcing Korean clinics to ration 99mTc doses. Cardiology centers extended imaging windows and curtailed elective studies, undercutting procedure volumes. Reliance on aged foreign reactors exposes Korea to geopolitical and maintenance shocks, pressuring procurement budgets. Accelerated domestic actinium-225 and Ga-68 programs mitigate but do not yet eliminate risk. Supply instability remains the largest drag on the South Korea nuclear medicine market.
Other drivers and restraints analyzed in the detailed report include:
Roll-out of Domestic Ga-68 Generator Manufacturing Capacity / Hospital Privatization Accelerates Equipment Refresh Cycles / High Capital Cost of PET/MR Limiting Provincial Access /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
The Equipment segment captured 53.45% of the South Korea nuclear medicine market share in 2024, underscoring provider commitment to high-resolution molecular imaging. Rapid rollout of digital detector technology improves sensitivity, letting hospitals justify premium pricing. Domestic Ga-68 production lowers tracer overhead, raising PET utilization rates across oncology and neurology. SPECT retains a strong installed base, yet faces competitive displacement in capital budgets. Equipment vendors increasingly bundle AI reconstruction to differentiate offerings, supporting higher average-selling prices.
Radioisotopes is projected to expand at an 8.12% CAGR on a value basis through 2030 as provincial hospitals favor its lower entry cost. Hybrid SPECT/CT upgrades extend the modality's lifespan by improving anatomical localization in cardiology and thyroid imaging. The radioisotope sub-segment benefits from steady technetium-99m demand despite global supply volatility. Cyclotron-enabled copper-64 and gallium-68 pipelines diversify tracer options, reinforcing resilience. Overall, the South Korea nuclear medicine market continues to tilt toward PET while sustaining niche opportunities in SPECT and emerging therapeutic isotopes.
The Nuclear Medicine Market Report is Segmented by Product (Equipment, Radioisotopes Including SPECT and PET Isotopes), Application (Cardiology, Neurology, Thyroid, Oncology, Other Applications), End User (Hospitals, Diagnostic Imaging Centres, Academic & Research Institutes), and Geography (South Korea). The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
GE HealthCare Technologies Inc. / Siemens Healthineers / Koninklijke Philips / Canon / United Imaging Healthcare Co., Ltd. / Eckert & Ziegler AG / IBA SA / Dongkook Pharm Co., Ltd. / FutureChem Co., Ltd. / Bracco Imaging S.p.A. / DuChemBIO / KAERI / KIRAMS / NuCare / Samyoung Unitech / Genoray /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing oncology PET/CT demand driven by aging population
4.2.2 Government reimbursement expansion for dementia PET tracers
4.2.3 Roll-out of domestic Ga-68 generator manufacturing capacity
4.2.4 Hospital privatisation accelerating equipment refresh cycles
4.2.5 AI-based image-reconstruction lowering dose & scan-time
4.2.6 Cyclotron build-out linked to theranostics clinical trials
4.3 Market Restraints
4.3.1 Radiopharmaceutical supply chain intermittency
4.3.2 High capital cost of PET/MR limiting provincial access
4.3.3 Shortage of certified nuclear-medicine technologists
4.3.4 Stringent MOHW radio-isotope transport regulations
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Suppliers
4.7.3 Bargaining Power of Buyers
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts
5.1 By Product (Value)
5.1.1 Equipment
5.1.2 Radioisotopes
5.1.2.1 SPECT Radioisotopes
5.1.2.1.1 Technetium-99m (Tc-99m)
5.1.2.1.2 Thallium-201 (Tl-201)
5.1.2.1.3 Gallium-67 (Ga-67)
5.1.2.1.4 Iodine-123 (I-123)
5.1.2.1.5 Other SPECT Isotopes
5.1.2.2 PET Radioisotopes
5.1.2.2.1 Fluorine-18 (F-18)
5.1.2.2.2 Rubidium-82 (Rb-82)
5.1.2.2.3 Other PET Isotopes
5.2 By Application (Value)
5.2.1 Cardiology
5.2.2 Neurology
5.2.3 Thyroid
5.2.4 Oncology
5.2.5 Other Applications
5.3 By End User (Value)
5.3.1 Hospitals
5.3.2 Diagnostic Imaging Centres
5.3.3 Academic & Research Institutes
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global-level Overview, Market-level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.3.1 GE HealthCare Technologies Inc.
6.3.2 Siemens Healthineers AG
6.3.3 Koninklijke Philips N.V.
6.3.4 Canon Medical Systems Corp.
6.3.5 United Imaging Healthcare Co., Ltd.
6.3.6 Eckert & Ziegler AG
6.3.7 IBA SA
6.3.8 Dongkook Pharm Co., Ltd.
6.3.9 FutureChem Co., Ltd.
6.3.10 Bracco Imaging S.p.A.
6.3.11 DuChemBIO Co. Ltd
6.3.12 KAERI (Korea Atomic Energy Research Institute)
6.3.13 KIRAMS (Korea Institute of Radiological & Medical Sciences)
6.3.14 NuCare Inc.
6.3.15 Samyoung Unitech
6.3.16 Genoray
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security